Records 1 - 9
| Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (7): 1583-90.
Bohanes Pierre, Rankin Cathryn J, Blanke Charles D, Winder Thomas, Ulrich Cornelia M, Smalley Stephen R, Rich Tyvin A, Martensen James A, Benson Al B, Mayer Robert J, Cripps Christine M, Danenberg Kathleen, Makar Karen W, Zhang Wu, Benedetti Jacqueline K, Lenz Heinz-Jos
| Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
American journal of clinical oncology 2015 Mar .
Osti Mattia F, Nicosia Luca, Agolli Linda, Gentile Giovanna, Falco Teresa, Bracci Stefano, Di Nardo Francesco, Minniti Giuseppe, De Sanctis Vitaliana, Valeriani Maurizio, Maglio Marianna, Borro Marina, Simmaco Maurizio, Enrici Riccardo
| DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (2): 713-8.
Guo Cheng-Xian, Yang Guo-Ping, Pei Qi, Yin Ji-Ye, Tan Hong-Yi, Yuan Ho
| Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
PloS one 2013 8 (7): e69039.
Lai Ching-Yu, Hsieh Ling-Ling, Sung Fung-Chang, Tang Reiping, Bai Chyi-Huey, Wu Fang-Yang, Chiou Hung-Yi, Yeh Chih-Chi
| Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Current medical research and opinion 2011 Jul 27 (7): 1295-302.
Canbay Emel, Cakmakoglu Bedia, Zeybek Umit, Sozen Seyma, Cacina Canan, Gulluoglu Mine, Balik Emre, Bulut Turker, Yamaner Sumer, Bugra Durs
| Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
The pharmacogenomics journal 2011 Jun 11 (3): 214-26.
Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso M L, Biason P, Visentin M, Nitti D, Toffoli
| Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.
Journal of cancer research and clinical oncology 2010 Oct 136 (10): 1517-25.
Wang Jingwen, Zhao Yang, Jiang Jing, Gajalakshmi Vendhan, Kuriki Kiyonori, Nakamura Seiichi, Akasaka Susumu, Ishikawa Hideki, Suzuki Sadao, Nagaya Teruo, Tokudome Shink
| The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.
Cancer genetics and cytogenetics 2005 Nov 163 (1): 38-43.
Jin Ming-Juan, Chen Kun, Song Liang, Fan Chun-Hong, Chen Qing, Zhu Yi-Min, Ma Xin-Yuan, Yao Kai-Y
| Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan.
BMC cancer 2005 Jan 5 (): 12.
Yeh Chih-Ching, Sung Fung-Chang, Tang Reiping, Chang-Chieh Chung Rong, Hsieh Ling-Li